Healthcare is a topic tracked in our intelligence system with 5 linked articles.
The American Diabetes Association released its long-awaited review of the June ejections of five members from its scientific sessions, citing a 'written threat' of protest while conceding its code of conduct never explicitly prohibited the conduct that triggered the removals.
STAT publishes a caregiver's firsthand account of one family's journey through the clinical trial for daraxonrasib (Rasonque), the newly FDA-approved pancreatic cancer drug — humanizing color, not decision-grade intelligence.
STAT+ reports from the National Association of Medicaid Directors fall conference, where state officials are scrambling to implement new Medicaid work requirements — described as one of the biggest changes to the program in decades — with less than 80 days until their deadline, as CMS Administrator Mehmet Oz urged states to treat the rollout as a 'great national research project.'
An AI analysis of CT scans reportedly found coronary inflammation in 42.9% of patients — a headline-level clinical statistic relevant to AI cardiac-diagnostics market sizing, but the provided content contains no company, deal, or strategic detail.
Detailed trial data confirm Moderna and Merck's personalized mRNA cancer vaccine (mRNA-4157/V940) met key endpoints, cutting melanoma recurrence risk by 42% versus standard treatment.
U.S. health insurance premiums jumped 9% in 2026 while the share of uninsured working-age adults rose, and half of the uninsured skipped needed care due to cost, per a new survey.
Subscribe for real-time topic updates and unlimited access to our intelligence platform.